Biocon Limited Share Price and Company Fundamentals
Last traded: Today at 10:00 AM
Biocon Limited, together with its subsidiaries, manufactures and sells biotechnology products and research services in India, the United States, Ireland, rest of the European Union, and internationally. It operates through Generics, Biosimilars, and Research segments. The company offers generic formulations and API products, including cardiovascular, anti-diabetics, obesity, multiple sclerosis, anti-fungal, anti-cancer, immunosuppressants, and specialty molecules; and biosimilars products consisting of pegfilgrastim, trastuzumab, bevacizumab, adalimumab, etanercept, ustekinumab, glargine, aspart, insulins, and aflibercept. It also provides integrated discovery, development, and manufacturing services to pharmaceutical, biotechnology, animal healthcare, consumer goods, and agrochemical companies. In addition, the company offers enzyme, biopharmaceutical, and medicinal goods; contract research and manufacturing services, and other research and development in the fields of pharmaceuticals, drug discovery, biotechnology pharmaceuticals, and medicinal sciences, etc.; clinical research; and business support and development, and marketing services. Biocon Limited was incorporated in 1978 and is headquartered in Bengaluru, India.
Key Metrics
PE ratio
74.19
PB ratio
1.74
Dividend yield
0.14%
Beta
0.25
Market cap
₹587.49B
Enterprise value
₹649.90B
Company profile
| Industry / Sector | Biotechnology / Healthcare |
|---|---|
| Website | https://www.biocon.com |
| Mailing address | 20th KM, Hosur Road Electronic City Bengaluru 560100 India |
| Phone / Fax | 91 80 2808 2808 / 91 80 2852 3423 |
Dividends
Dividend yield
0.14%
Dividend amount
₹0.50
Payout ratio
10.25%
5Y Avg. yield
-%
Biocon Limited paid ₹0.50 dividend and the ex-dividend date was 04 Jul 2025.The dividend payout ratio is 10.25%. The dividend payout ratio is defined as the amout of dividend paid divided by the earnings of the company.BIOCON dividend payout ratio is less than 70. This is ideal as it gives company room to grow the dividends and also the excess earnings can be invested in company for growth.
Company Executives
As of Apr 2026, following are the company executives and directors listed on Biocon Limited.
| Name | Title | Age | Total Pay |
|---|---|---|---|
| Dr. Kiran Mazumdar-Shaw B.Sc (Hons), B.Sc. | Founder & Executive Chairperson | 72 | |
| Mr. Shreehas Pradeep Tambe MTech | CEO, MD & Additional Director | 51 | |
| Mr. Kedar Narayan Upadhye CS, MBA | Chief Financial Officer | 48 | |
| Dr. Mandar S. Ghatnekar | Chief Technology Officer | ||
| Mr. Saurabh Paliwal | Head of Investor Relations | ||
| Mr. Rajesh Umakant Shanoy | Company Secretary & Compliance Officer | ||
| Ms. Seema Shah Ahuja BA, MBA | SVP & Global Head Corporate Communications & Corporate Brand Biocon Group | 59 | |
| Mr. Naveen Narayanan | Chief Human Resources Officer | ||
| Mr. Paul Vazhayil Thomas | Chief Commercial Officer, U.S. & Portfolio Strategy & Business Dev, Adv mkts of Biosimilars Business | 52 | |
| Mr. Akhilesh Kumar Nand | Head of Governance, Risk & Compliance |
Profitability and management effectiveness
Profit margin
3.59%
Operating margin
7.63%
Return on assets
-
Return on equity
-
Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.
The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.
Valuation and Trading Info
The market capitalization of Biocon Limited is 587.49B and its enterprise value is 649.90B. The enterprise value to revenue ratio of BIOCON is 3.86. The enterprise value to EBITDA ratio of BIOCON is 19.41.
The BIOCON's stocks Beta value is 0.25 making it 75% less volatile compared to NSE market index. Technology stocks and small caps tend to have higher betas than the market benchmark. This indicates that adding the stock to a portfolio will increase the portfolio’s risk, but also increase its expected return. On the other hand utility stocks often have low betas because they tend to move more slowly than market averages.
Biocon Limited (NSE:BIOCON) Frequently Asked Questions
1. What is Biocon Limited's Stock Symbol?
Biocon Limited trades on NSE under the ticker symbol "BIOCON".
2. What is Biocon Limited's stock price today?
One share of BIOCON stock can currently be purchased for approximately ₹362.8.
3. How can I contact Biocon Limited?
Biocon Limited's mailing address is 20th KM, Hosur Road Electronic City Bengaluru 560100 India. The company can be reached via phone at 91 80 2808 2808.
4. What is Biocon Limited's official website?
The official website of Biocon Limited is https://www.biocon.com.